Simon Rule

98PUBLICATIONS

348CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursApplied statistics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (98)

Sort by Publication Date:

|Jul 13, 2026

Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study.

|Jul 09, 2026

Reversible and irreversible BTK inhibition promotes stem-like functional multipotency, persistence, and antitumor efficacy of CD19-directed CAR T cells in mantle cell lymphoma.

|Jul 02, 2026

BRG1-mediated suppression of ferroptosis underlies BTK inhibitor resistance.

|Jul 01, 2026

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

|Jun 04, 2026

Five-year survival outcomes from TRANSCEND NHL 001 of lisocabtagene maraleucel in R/R LBCL.

|Apr 25, 2026

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

Pageof 17

Frequent Collaborators

19 joint publications

Preetesh Jain

10 joint publications

Sairah Ahmed

Jason Westin

Yang Liu

Sattva S Neelapu

Yixin Yao

Yucai Wang

Chi Young Ok

Holly Hill

Vivian Jiang

Frequent Collaborators

19 joint publications

Preetesh Jain

10 joint publications

Sairah Ahmed

9 joint publications

Jason Westin

8 joint publications

Yang Liu